Expert opinion on drug safety
-
Expert Opin Drug Saf · Aug 2020
ReviewA drug safety evaluation of atezolizumab in locally advanced or metastatic urothelial carcinoma.
Immune checkpoint inhibitors (ICIs) have rapidly changed the treatment landscape, demonstrating dramatic clinical efficacy in various cancers. ⋯ Atezolizumab is a drug with a favorable toxicity profile and will obtain more indications in the future in UC and other cancers. Treating physicians should be aware of treatment-related and immune-related adverse events associated with the drug.